SOURCE-LINKED STUDY SUMMARY
Bone health in older men.
Abstract summarizedQuality not appraised
- What was studied
- A review of osteoporosis risk, screening and treatment in older men.
- Who / model studied
- Evidence concerning older men, including men with hypogonadism and secondary causes of bone loss. This was a review rather than a new patient cohort.
- Studied dose & schedule
- Dose and schedule have not yet been extracted for this summary.
- What the study found
- Bisphosphonates remain first-line treatment. Testosterone replacement improves bone density in hypogonadal men, but has not been shown to reduce major osteoporotic fractures.
- Limitations & context
- Male-specific fracture evidence remains limited, and the review identifies gaps in long-term safety, treatment sequencing and secondary prevention.
Read summary source ↗ · Prepared 9/15/2026 · AI-assisted, source-based summary
Review record & corrections
Summary prepared: . Source scope: abstract. This is an AI-assisted source summary, not an independent clinician sign-off.
No public field-by-field revision history is available for this card yet. The date above is the summary date, not proof that every field was updated then.
Inspect the source · Correction policyResearch findings apply to the population and conditions studied. This educational summary is not a treatment recommendation or a formal assessment of study quality.
Original publication ↗ · DOI: 10.1016/j.maturitas.2026.109125